You are here

ITCA 650

FDA panel votes against diabetes implant due to safety concerns

Reuters

Fri, 09/22/23 - 11:48 am

FDA offers former biotech unicorn Intarcia a chance for a panel review

BioPharma Dive

Thu, 02/9/23 - 06:04 pm

Intarcia's speed bump at the FDA turns into a roadblock, as regulators once again turn thumbs down on diabetes drug/device

Endpoints

Tue, 03/10/20 - 11:28 pm

drug-device combos

Diabetes 'Unicorn' Intarcia Hits Major Milestone

Fortune

Fri, 05/6/16 - 10:33 am

type 2 diabetes

Intarcia’s diabetes treatment beats $6B Merck drug in head-to-head trial

Bizjournals.com

Tue, 08/18/15 - 09:26 pm

type 2 diabetes

Boston's Intarcia now one step closer to upending type 2 diabetes market

Bizjournals.com

Mon, 06/8/15 - 11:23 am

type 2 diabetes

Intarcia's annual diabetes treatment aces two Phase III trials

Fierce Biotech

Thu, 10/2/14 - 10:28 am

Intarcia Says It’s in Partner Talks Beyond Diabetes Drugs

Bloomberg

Mon, 01/7/13 - 07:06 pm